2012
DOI: 10.1016/j.bmcl.2012.08.069
|View full text |Cite
|
Sign up to set email alerts
|

Serum stability of selected decapeptide agonists of KISS1R using pseudopeptides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
38
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 29 publications
(39 citation statements)
references
References 43 publications
1
38
0
Order By: Relevance
“…Using this method, stability studies demonstrated that the peptide is rapidly degraded with a half-life of 1.7 min at 37 8C, the main degradation product being the N-terminal tyrosine-deleted peptide (Liu et al 2013). It is also worth noting that Arg9 methylation confers greater resistance of the peptide to trypsin while improving its agonistic potency (Asami et al 2012).…”
Section: Structure-activity Relationships and Evolution Of Kisspeptinsmentioning
confidence: 99%
See 2 more Smart Citations
“…Using this method, stability studies demonstrated that the peptide is rapidly degraded with a half-life of 1.7 min at 37 8C, the main degradation product being the N-terminal tyrosine-deleted peptide (Liu et al 2013). It is also worth noting that Arg9 methylation confers greater resistance of the peptide to trypsin while improving its agonistic potency (Asami et al 2012).…”
Section: Structure-activity Relationships and Evolution Of Kisspeptinsmentioning
confidence: 99%
“…In contrast, substitution of some amino acids of the N-terminal end with their D-enantiomers can improve the peptide activity and/or its resistance to proteases. For instance, replacement of Trp3 by D-Trp yields to a compound with high metabolic stability in serum and good agonistic activity (Asami et al 2012). Similarly, substitution of Tyr1 by D-Tyr increases the biological activity of the peptide in vivo (Curtis et al 2010).…”
Section: Structure-activity Relationships and Evolution Of Kisspeptinsmentioning
confidence: 99%
See 1 more Smart Citation
“…However, its in vitro EC 50 value is more than 0.1 m M and the GnRH-releasing activity in vivo remains to be confirmed. On the other hand, short-form peptide agonist analogs of Kp-10 have been reported by us and other investigators [31,[33][34][35] .…”
Section: Kiss1r Agonistsmentioning
confidence: 99%
“…Indeed, Kp-10 derivatives with D -Tyr 45 showed acceptable activity and evaded N-terminal degradation, and the residual ratio of an analog with D -Tyr 45 and Arg(Me) 53 was highly improved to 18.1% after 1 h of incubation in mouse serum. However, several metabolites were still observed in the electrospray ionization mass spectrometry spectra, including products of cleavage between Trp 47 -Asn 48 , Phe 50 -Gly 51 , and Gly 51 -Leu 52 [33] . 51 showed improved metabolic stability but reduced in vitro agonistic activity.…”
Section: -Asn 46mentioning
confidence: 99%